- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05852795
Virtual Reality Experiences as Tools to Support Mental Health in Parents of Children With Autism (Mind-VR)
Evaluating the Behavioral Effect of a Virtual Reality-mediated Mindfulness-based Interventions on Parents of Children With Autism: a Randomized Controlled Trial (RCT) Study
Mindfulness is a technique that involves the intentional and non-judgmental regulation of attention to the present moment, with curiosity, openness, and acceptance, as per its definition. Mindfulness-based interventions (MBIs) have been used to manage mood disorders in various clinical and non-clinical settings, including neurological patients and cardiovascular diseases. Studies have consistently demonstrated that MBIs reduce depressive and anxiety symptoms, as well as rumination. MBIs are considered an alternative and effective treatment for reducing psychological stress in the management of different health conditions. Virtual reality (VR) has recently been proposed as an intermediate interface to help patients with emotional dysregulation learn mindfulness practices.
Within this context, new approaches to mental health integrating advanced technologies such as VR can play a critical role. In this interventional study we will seek to demonstrate the effectiveness of a virtual reality-mediated mindfulness-based intervention in a particular group of people who are constantly experiencing psychological distress due to caring for children with autism spectrum disorders (ASD).
Study Overview
Status
Conditions
Detailed Description
In this study participants will be randomly assigned to an experimental or control groups according to the main treatment. Participants in the experimental group will undergo 8 VR sessions by observing a scenario accompanied by a voice audio guide, whereas participants in the control group will complete the 8 VR sessions by observing scenery accompanied only by the sounds of nature. All groups will be treated one time a week for 1h sessions for 8 consecutive weeks.
Participant recruitment: The families of children with ASD will be recruited at the clinical facilities of the Institute for Biomedical Research and Innovation of the National Research Council of Italy (IRIB-CNR) in Messina as part of an ongoing research program.
Allocation of the sample: Eligible participants who will meet the inclusion criteria will receive written information about the procedure and be asked to sign the consent form indicating their willingness to participate in the study. Only qualified individuals who provided informed consent will be randomly assigned to the experimental or control group in a 1:1 manner. Participants will then receive information regarding the allocation result. The randomization will be performed using a computer-generated, site-stratified, randomization schedule. Randomization will be stratified according to age, sex and educational level. For each stratum, random numbers will be assigned to the participants and put into envelopes; it will be determined randomly whether the even or odd number would enter the experimental group. Participants will be assigned to the study according to the numbers they received on opening the envelopes.
Withdrawn criteria: Participants will be considered withdrawn if any of the following occurs: (1) participant chooses to withdraw from the study at any time, (2) intolerable adverse effects, (3) major violation of the study protocol, and (4) other circumstances that would endanger the health of the subject if he/she would to continue his/her participation in the trial.
Immersive virtual environments: Virtual reality experience will be made by using 8 relaxing virtual scenarios (e.g., naturalistic environments) created by BECOME s.r.l. (https://www.discoverbecome.com). The virtual experiences will be offered through the Oculus Quest 2 (marketed since November 2021 as Meta Quest 2)
Sample size: Power size calculation will be performed with GPower 3.1. Considering an anticipated effect size (f) of 1, an alpha set at 0.05, 2 groups, and a 0.95 statistical power, the total sample size required is N = 46.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Messina, Italy, 98164
- Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- being parent of a child diagnosed with autism
- absence of pharmacotherapy that could interfere with the measured data (psychoactive drugs, anti-hypertensive, anti-depressants)
- no significant visual impairment
Exclusion Criteria:
- history of psychiatric diagnosis
- presence of medical disorders (heart disease or blood pressure, neurological disorders, epilepsy)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
VR-based and audio-based mindfulness experience.
Partecipants watch VR scenario and receive a guided mindfulness practice.
|
The Experimental will undergo 8 weekly sessions of immersive experience lasting 30 minutes. Each session is divided as follows:
This intervention will produce a multisensory experience merging visual and digital auditory stimuli. The audio recording also included some ambient natural sound effects, to make the practice more immersive. |
|
Other: Control Group
VR-based mindfulness experience.
Participants watch VR scenario without experiencing voice guided mindfulness practice.
|
The Control will undergo 8 weekly sessions of immersive experience lasting 30 minutes. Each session is divided as follows:
This intervention will produce a monosensorial experience with video guided stimulation of naturalistic scenarios. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parental Stress Index/Short Form (PSI/SF)
Time Frame: The test needs approximately 10 minutes to complete
|
The Parenting Stress Index/Short Form (PSI/SF) is a self-administered questionnaire that aims to identify factors that may negatively impact a child's development
|
The test needs approximately 10 minutes to complete
|
|
Mindful Attention Awareness Scale (MAAS)
Time Frame: The test needs approximately 10 minutes to complete
|
The Mindful Attention Awareness Scale (MAAS) consists of 15 items, each scored on a Likert scale ranging from 1 (almost always) to 6 (almost never).
The total score on the MAAS ranges from a minimum of 15 (reflecting a response of 1 on all items) to a maximum of 90 (reflecting a response of 6 on all items).
Higher scores on the MAAS indicate greater clinical improvement in a patient's capacity for present moment awareness.
|
The test needs approximately 10 minutes to complete
|
|
State-Trait Anxiety Inventory (STAI)
Time Frame: The test needs approximately 10 minutes to complete
|
The total State-Trait Anxiety Inventory (STAI) score is between 20 and 80 with a predictive threshold value of anxious symptomatology set at 40.
The level of severity can also be defined according to a scalar criterion: from 40 to 50 mild form, from 50 to 60 moderate, > of 60 serious.
|
The test needs approximately 10 minutes to complete
|
|
Beck Depression Inventory (BDI)
Time Frame: The test needs approximately 10 minutes to complete
|
The Beck Depression Inventory is a depression rating scale that can be used with individuals 13 years of age and older and assesses symptoms of depression on a scale of 0 to 3 based on 21 specific items.
|
The test needs approximately 10 minutes to complete
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart rate (HR)
Time Frame: The test needs approximately 30 minutes
|
The BioHarness 3 uses an electrocardiogram (ECG) sensor to detect the electrical activity of the heart and calculate heart rate in beats per minute (bpm).
|
The test needs approximately 30 minutes
|
|
Heart rate variability (HRV)
Time Frame: The test needs approximately 30 minutes
|
The BioHarness 3 measures the time intervals between successive heart beats and calculates Heart Rate Variability (HRV) in milliseconds (ms).
|
The test needs approximately 30 minutes
|
Collaborators and Investigators
Investigators
- Principal Investigator: Antonio Cerasa, antonio.cerasa@irib.cnr.it
Publications and helpful links
General Publications
- Failla C, Marino F, Bernardelli L, Gaggioli A, Doria G, Chila P, Minutoli R, Mangano R, Torrisi R, Tartarisco G, Bruschetta R, Arcuri F, Cerasa A, Pioggia G. Mediating Mindfulness-Based Interventions with Virtual Reality in Non-Clinical Populations: The State-of-the-Art. Healthcare (Basel). 2022 Jun 29;10(7):1220. doi: 10.3390/healthcare10071220.
- Puglisi A, Capri T, Pignolo L, Gismondo S, Chila P, Minutoli R, Marino F, Failla C, Arnao AA, Tartarisco G, Cerasa A, Pioggia G. Social Humanoid Robots for Children with Autism Spectrum Disorders: A Review of Modalities, Indications, and Pitfalls. Children (Basel). 2022 Jun 25;9(7):953. doi: 10.3390/children9070953.
- Marino F, Failla C, Carrozza C, Ciminata M, Chila P, Minutoli R, Genovese S, Puglisi A, Arnao AA, Tartarisco G, Corpina F, Gangemi S, Ruta L, Cerasa A, Vagni D, Pioggia G. Mindfulness-Based Interventions for Physical and Psychological Wellbeing in Cardiovascular Diseases: A Systematic Review and Meta-Analysis. Brain Sci. 2021 May 29;11(6):727. doi: 10.3390/brainsci11060727.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CNR-IRIB-PRO-2023-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on Virtual Reality-mediated Mindfulness-Based Interventions
-
Hsin Yi LuRecruitingBreast Cancer | Chemotherapy | Virtual Reality | MindfulnessTaiwan
-
University of California, Los AngelesWithdrawnDepression | Stress | Anxiety | Pain, Acute | Pain, Chronic
-
Manhattan Psychiatric CenterNational Institute of Mental Health (NIMH)RecruitingAggression | Schizoaffecitve Disorder | Schizophrenia DisorderUnited States
-
University of Missouri-ColumbiaActive, not recruitingPain, Chronic | Insomnia ChronicUnited States
-
Tongji HospitalNot yet recruiting
-
Kutahya Health Sciences UniversityThe Scientific and Technological Research Council of TurkeyCompletedStress | Anxiety | Virtual Reality | Mindfulness | Postoperative Recovery | Cardiovascular SurgeryTurkey (Türkiye)
-
University of North Carolina, Chapel HillNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)RecruitingAnterior Cruciate Ligament InjuryUnited States
-
Istanbul UniversityCompletedCarpal Tunnel SyndromeTurkey
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingDepression - Major Depressive Disorder | Depression Chronic | Treatment-Resistant Major Depressive Disorder | Depression DisorderSpain
-
Chinese University of Hong KongNot yet recruitingStress | Virtual Reality | Mindfulness | StudentChina